Dear Friends,
July 2011
Lotus owes its buoyancy to three fundamental principles, which are part of its DNA: its dedication and commitment, quality and performance, and its ability to provide the highest level of customer satisfaction.
We know that it is our quality – quality in our services & operations, quality in our people and quality in our relationships that has delighted customers for years and why our sponsors’ consider Lotus as their right partners for all their study requirements.
As a testimony of our commitment to quality and excellence, Lotus has been awarded the prestigious International Star for Leadership in Quality Award (ISLQ) in the Gold category at the B.I.D International Quality Convention held in Paris this year. The award constituted by the B.I.D (Business Initiatives Directions), recognizes Lotus for “Commitment to Quality, Leadership, Technology, and Innovation, thereby representing success for India in the business world.”
The award is truly an achievement for our company and country, as it’s the first time an Indian CRO has been recognised by B.I.D, which is currently the most important private organization in the world presenting a Quality Award.
Team Lotus is proud of having earned the ISLQ International Star for Leadership in Quality Award that acknowledges our strong commitment to quality and excellence, and we will continue to thrive on our promise. We look forward to continue our journey in continuous improvement of processes, systems and people, and to deliver quality in all what we do.
March 2011
India as a knowledge hub is now well documented and so too its new found status as a preferred outsourcing destination and Clinical Research Industry is part of this story. Over the years Indian regulatory guidelines have also been streamlined making it on par with international standards thereby ensuring validity and accountability of trials carried out in India.
Lotus Labs Pvt. Ltd., the most admired clinical research organization of India, is also keeping pace with the developments happening globally and carving a niche for its innovative service offerings so as to reiterate the status as a preferred partner for the Global Pharmaceutical industry.
Our quest to become a premier organization has been a continuous process. We have robust processes that assure generation of high quality data and addresses quality requirements of our clients. Importantly we strive to meet client expectations by customizing services and our dedicated delivery standards offers the experience of customer delight to each of our valued clients.
Given our superior work ethos it is not surprising that we have partnered 3 of the top 5 generic multinational pharmaceutical firms. Lotus Labs has all regulatory approvals across markets which mean hassle free and seamless workflow. Also we have sensitized people, processes and products to the core philosophy of best practices and compliance.
Having partnered majors in the regulated markets of the US and Europe, we at Lotus Labs are consciously looking at opportunities in the emerging markets, including Middle East, Turkey, Brazil, China, Russia; where we plan to tap the generic drug manufacturers. On the offerings portfolio, we are adding more services including Clinical Data Management that would make Lotus an end-to-end solution provider addressing our partner’s 3600 Clinical Research requirement.
We at Lotus Labs have evolved over the years and would strive to march ahead of the competition. Our Centre of Excellence is looking for a synergistic partnership that heralds hope to teeming millions.
I personally welcome you to experience the services offered by Lotus Labs and reap the difference it could make to your business.
Dr. Yati Chugh
Managing Director